PT1202722E - Usos para o tratamento ou prevencao de disturbios do sono usando doses muito baixas de ciclobenzaprina - Google Patents

Usos para o tratamento ou prevencao de disturbios do sono usando doses muito baixas de ciclobenzaprina

Info

Publication number
PT1202722E
PT1202722E PT00953996T PT00953996T PT1202722E PT 1202722 E PT1202722 E PT 1202722E PT 00953996 T PT00953996 T PT 00953996T PT 00953996 T PT00953996 T PT 00953996T PT 1202722 E PT1202722 E PT 1202722E
Authority
PT
Portugal
Prior art keywords
cyclobenzaprine
doses
prevention
treatment
low
Prior art date
Application number
PT00953996T
Other languages
English (en)
Inventor
Iredell W Iglehart Iii
Original Assignee
L & L Technologies Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L & L Technologies Llc filed Critical L & L Technologies Llc
Publication of PT1202722E publication Critical patent/PT1202722E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
PT00953996T 1999-08-13 2000-08-11 Usos para o tratamento ou prevencao de disturbios do sono usando doses muito baixas de ciclobenzaprina PT1202722E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14888199P 1999-08-13 1999-08-13

Publications (1)

Publication Number Publication Date
PT1202722E true PT1202722E (pt) 2005-11-30

Family

ID=22527835

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00953996T PT1202722E (pt) 1999-08-13 2000-08-11 Usos para o tratamento ou prevencao de disturbios do sono usando doses muito baixas de ciclobenzaprina

Country Status (18)

Country Link
US (3) US6395788B1 (pt)
EP (1) EP1202722B1 (pt)
JP (1) JP2003506484A (pt)
AR (1) AR025110A1 (pt)
AT (1) ATE299369T1 (pt)
AU (1) AU6635400A (pt)
BR (1) BR0013017A (pt)
CA (1) CA2380432A1 (pt)
DE (1) DE60021266T2 (pt)
ES (2) ES2245944T3 (pt)
GB (1) GB2368522A (pt)
HK (2) HK1047691B (pt)
IL (1) IL147777A0 (pt)
MX (1) MXPA02001569A (pt)
NZ (1) NZ516749A (pt)
PT (1) PT1202722E (pt)
WO (1) WO2001012175A1 (pt)
ZA (2) ZA200200619B (pt)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000048581A2 (en) * 1999-02-18 2000-08-24 Novartis Ag Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
US6602911B2 (en) * 2001-11-05 2003-08-05 Cypress Bioscience, Inc. Methods of treating fibromyalgia
GB0128674D0 (en) * 2001-11-30 2002-01-23 Boots Co Plc Treatment of sleep disorders and the like
JP4578083B2 (ja) * 2003-09-30 2010-11-10 小林製薬株式会社 催眠剤組成物
US7994220B2 (en) * 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
US20070087055A1 (en) * 2005-10-14 2007-04-19 David Jan Directly compressible extended release alprazolam formulation
WO2007064697A1 (en) * 2005-12-01 2007-06-07 Auspex Pharmaceuticals, Inc. Substituted phenethylamines with serotoninergic and/or norepinephrinergic activity
AU2007217783A1 (en) * 2006-02-16 2007-08-30 Imthera Medical, Inc. An RFID based apparatus, system, and method for therapeutic treatment of a patient
US20100179215A1 (en) * 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
HUE031070T2 (en) 2007-03-15 2017-06-28 Auspex Pharmaceuticals Inc Deuterated d9-venlafaxine
WO2009048581A1 (en) 2007-10-09 2009-04-16 Imthera Medical, Inc. System and method for neural stimulation
US8629135B2 (en) * 2008-07-14 2014-01-14 Queen's University At Kingston Pharmaceutical compositions comprising RET inhibitors and methods for the treatment of cancer
WO2010042404A1 (en) 2008-10-09 2010-04-15 Imthera Medical, Inc. Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue
US9498440B2 (en) 2009-05-22 2016-11-22 Inventia Healthcare Private Limited Extended release pharmaceutical compositions
AU2010318651A1 (en) * 2009-11-10 2012-05-03 Imthera Medical, Inc. System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue
WO2011062614A1 (en) 2009-11-20 2011-05-26 Tonix Pharmaceuticals, Inc. Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine
US20110319389A1 (en) * 2010-06-24 2011-12-29 Tonix Pharmaceuticals, Inc. Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine
US20120232159A1 (en) * 2011-03-07 2012-09-13 Tonix Pharmaceuticals, Inc. Methods and Compositions for Treating Depression using Cyclobenzaprine
ITMI20110558A1 (it) * 2011-04-06 2012-10-07 Campiglio Consulting Srl Composizione farmaceutica contenente ciclobenzaprina adatta alla somministrazione endonasale
WO2013168004A2 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of fibromyalgia pain
TWI683660B (zh) 2012-06-15 2020-02-01 美商托尼克製藥有限公司 供穿黏膜吸收之組合物及方法
WO2014145156A2 (en) 2013-03-15 2014-09-18 Tonix Pharmaceuticals, Inc. Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride
BR112017005231A2 (pt) 2014-09-18 2018-03-13 Tonix Pharma Holdings Ltd formulações eutéticas de cloridrato de ciclobenzaprina
JP2020526592A (ja) 2017-07-13 2020-08-31 トニックス ファーマシューティカルズ ホールディング コーポレーション シクロベンザプリン類似体及びアミトリプチレン類似体
IL275289B2 (en) * 2017-12-11 2024-01-01 Tonix Pharma Holdings Ltd Cyclobenzaprine for the treatment of restlessness, psychosis and cognitive decline in dementia and neurodegenerative diseases
US20190381056A1 (en) 2018-06-17 2019-12-19 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US20220117915A1 (en) * 2018-08-20 2022-04-21 Tonix Pharma Holdings Limited Methods of treating acute stress disorder and posttraumatic stress disorder
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US20210315841A1 (en) * 2020-04-08 2021-10-14 Tonix Pharmaceuticals Holding Corp. Cyclobenzaprine treatment for sexual dysfunction
US20240009146A1 (en) 2020-11-20 2024-01-11 Tonix Pharmaceuticals Holding Corp. Cyclobenzaprine treatment for alcohol use disorder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1339636A (en) * 1917-02-23 1920-05-11 Tulloch Thomas Gregorie Fluid-tight joint for steam-pipes and the like
GB859187A (en) 1958-11-25 1961-01-18 United States Borax Chem Method for preparing substituted tris amino boranes
CA958643A (en) 1970-07-07 1974-12-03 Frosst (Charles E.) And Co. Pharmaceutical compositions containing cyclobenzaprine
FR2121529A1 (en) * 1971-01-05 1972-08-25 Merck & Co Inc Compsns contg cyclobenzaprine and indomethacin - chlordiazepoxide, phenylbutazone oxyphenbutazone or corticosteroid
AR025111A1 (es) * 1999-08-13 2002-11-06 Janus Pharmaceuticals Inc Metodos y composiciones para tratar trastornos de ansiedad generalizada

Also Published As

Publication number Publication date
ES2192156A1 (es) 2003-09-16
GB2368522A (en) 2002-05-08
US20040029869A1 (en) 2004-02-12
EP1202722B1 (en) 2005-07-13
US20010046988A1 (en) 2001-11-29
BR0013017A (pt) 2002-04-16
AR025110A1 (es) 2002-11-06
IL147777A0 (en) 2002-08-14
NZ516749A (en) 2004-03-26
ATE299369T1 (de) 2005-07-15
ZA200200619B (en) 2003-04-23
GB2368522A8 (en) 2002-06-13
CA2380432A1 (en) 2001-02-22
GB0202908D0 (en) 2002-03-27
US6395788B1 (en) 2002-05-28
JP2003506484A (ja) 2003-02-18
DE60021266T2 (de) 2006-05-24
MXPA02001569A (es) 2002-07-02
ES2245944T3 (es) 2006-02-01
ZA200200852B (en) 2003-07-30
WO2001012175A1 (en) 2001-02-22
ES2192156B1 (es) 2005-02-16
AU6635400A (en) 2001-03-13
EP1202722A1 (en) 2002-05-08
HK1047691B (zh) 2006-05-12
US6541523B2 (en) 2003-04-01
HK1047691A1 (en) 2003-03-07
DE60021266D1 (de) 2005-08-18
HK1047883A1 (zh) 2003-03-14
WO2001012175A8 (en) 2001-05-10

Similar Documents

Publication Publication Date Title
PT1202722E (pt) Usos para o tratamento ou prevencao de disturbios do sono usando doses muito baixas de ciclobenzaprina
AU2001247331A1 (en) Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
IL196301A0 (en) Medicament for the treatment of hapatitis c
HUP0400529A3 (en) Use of chlorpromazine and pentamidine for preparation of pharmaceutical compositions for the treatment of neoplastic disorders
IT1302365B1 (it) Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali
DK2052714T3 (da) Topisk gel-fremføringssystem til behandling af hudlidelser
IL160389A0 (en) Use of flibanserin for the treatment of sexual disorders
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
AU4256801A (en) Treatment of movement disorders
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
PL358306A1 (en) Compounds with 5-ht1a activity useful for treating disorders of the outer retina
NO20024775D0 (no) Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
ZA200107143B (en) Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders.
NO20024776L (no) Hydroksyfenyl-piperazinyl-metyl-benzamid derivater til behandling av smerte
HK1057332A1 (en) Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders
NO20023803D0 (no) Anvendelse av mirtazapin for behandling av sövnforstyrrelser
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
IL155237A0 (en) Combination therapy for the treatment of estrogen-sensitive disease
EE200100527A (et) Osanetandi kasutamine meeleoluhäirete raviks kasulike ravimite valmistamiseks
AR027958A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades vasculares, que comprende propionil l-carnitina y coenzima q10
FI20002612A0 (fi) Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi
HUP0301798A3 (en) Treatment of eating disorders using carboxyalkylethers
ES1044435Y (es) Dispositivo para produccion de vapor de bañeras y cabinas de hidromasaje.
IT1306143B1 (it) Composizione per la prevenzione ed il trattamento delle alterazionimentali e comportamentali.